The head of the Egyptian Drug Authority (EDA) has met with the Belarusian ambassador to Cairo to discuss strengthening cooperation in the pharmaceutical sector, including facilitating the registration of medical products and expanding access to international markets, the authority said.
The meeting between EDA Chairperson Ali El-Ghamrawy and Ambassador Sergei Terentiev covered several key files, most notably ways to streamline registration procedures for medical products and equipment and to explore technical cooperation between the EDA and its Belarusian counterpart. The stated aim is to positively impact import-export traffic and increase the competitiveness of pharmaceutical products in both countries.
In a statement, the EDA said El-Ghamrawy welcomed the Belarusian delegation and emphasised the importance of expanding technical and regulatory cooperation to enhance mutual product registration and support access to new markets.
El-Ghamrawy affirmed that the authority “gives special importance to strengthening cooperation with various international partners,” including Belarus, to help develop regulatory policies and improve the efficiency of the registration system. He added that these efforts are part of the EDA’s vision to increase the competitiveness of Egyptian medicine, facilitate trade, and support access to global markets for the benefit of the national economy and healthcare sector.
For his part, Ambassador Terentiev expressed his appreciation for the EDA’s role in developing the pharmaceutical sector and said its efforts reflect a serious commitment to global quality standards. He noted that Belarus looks forward to strengthening technical and institutional cooperation with Egypt to exchange expertise and open wider prospects for joint exports to new markets.
The meeting was also attended by senior EDA officials, including Dr. Amany Goudat, assistant to the Chairperson, and Osama Hatem, assistant to the chairperson for policy and international cooperation.
The EDA said the talks fall within its vision to consolidate international cooperation and exchange expertise with counterpart authorities globally. This helps support the national industry by opening new markets for Egyptian pharmaceutical products and encouraging the transfer of technology and adoption of global best practices, the authority added.
